139 related articles for article (PubMed ID: 25960239)
1. Application of the Apc(Min/+) mouse model for studying inflammation-associated intestinal tumor.
Wang L; Zhang Q
Biomed Pharmacother; 2015 Apr; 71():216-21. PubMed ID: 25960239
[TBL] [Abstract][Full Text] [Related]
2. Dual gene deficient models of Apc
Yu S; Yin Y; Wang Q; Wang L
Biomed Pharmacother; 2018 Dec; 108():600-609. PubMed ID: 30243094
[TBL] [Abstract][Full Text] [Related]
3. Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.
Büller NV; Rosekrans SL; Metcalfe C; Heijmans J; van Dop WA; Fessler E; Jansen M; Ahn C; Vermeulen JL; Westendorp BF; Robanus-Maandag EC; Offerhaus GJ; Medema JP; D'Haens GR; Wildenberg ME; de Sauvage FJ; Muncan V; van den Brink GR
Gastroenterology; 2015 Jan; 148(1):170-180.e6. PubMed ID: 25307863
[TBL] [Abstract][Full Text] [Related]
4. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
[TBL] [Abstract][Full Text] [Related]
6. Apc mice: models, modifiers and mutants.
McCart AE; Vickaryous NK; Silver A
Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
[TBL] [Abstract][Full Text] [Related]
7. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.
Dove WF; Cormier RT; Gould KA; Halberg RB; Merritt AJ; Newton MA; Shoemaker AR
Philos Trans R Soc Lond B Biol Sci; 1998 Jun; 353(1370):915-23. PubMed ID: 9684289
[TBL] [Abstract][Full Text] [Related]
8. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
9. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice.
Grill JI; Neumann J; Herbst A; Hiltwein F; Ofner A; Marschall MK; Wolf E; Kirchner T; Göke B; Schneider MR; Kolligs FT
Mol Cancer Res; 2014 Nov; 12(11):1655-62. PubMed ID: 25053805
[TBL] [Abstract][Full Text] [Related]
10. Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.
Kettunen HL; Kettunen AS; Rautonen NE
Cancer Res; 2003 Aug; 63(16):5136-42. PubMed ID: 12941845
[TBL] [Abstract][Full Text] [Related]
11. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
[TBL] [Abstract][Full Text] [Related]
12. Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
Uckun FM; Erbeck D; Qazi S; Venkatachalam T; Tibbles HE; Vassilev A
Arzneimittelforschung; 2007; 57(6):320-9. PubMed ID: 17688077
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous deletion of ATG5 in Apc(Min/+) mice promotes intestinal adenoma growth and enhances the antitumor efficacy of interferon-gamma.
Wang L; Wang Y; Lu Y; Zhang Q; Qu X
Cancer Biol Ther; 2015; 16(3):383-91. PubMed ID: 25695667
[TBL] [Abstract][Full Text] [Related]
14. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.
Fodde R; Edelmann W; Yang K; van Leeuwen C; Carlson C; Renault B; Breukel C; Alt E; Lipkin M; Khan PM
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8969-73. PubMed ID: 8090754
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Itf2 promotes intestinal tumorigenesis in Apc(Min/+) mice.
Grill JI; Herbst A; Brandl L; Kong L; Schneider MR; Kirchner T; Wolf E; Kolligs FT
Biochem Biophys Res Commun; 2015 May; 461(2):249-53. PubMed ID: 25869068
[TBL] [Abstract][Full Text] [Related]
16. Growth stimulation of intestinal tumours in Apc(Min/+) mice by dietary L-methionine supplementation.
Paulsen JE; Alexander J
Anticancer Res; 2001; 21(5):3281-4. PubMed ID: 11848484
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice.
Rao VP; Poutahidis T; Ge Z; Nambiar PR; Horwitz BH; Fox JG; Erdman SE
Cancer Res; 2006 Jan; 66(1):57-61. PubMed ID: 16397216
[TBL] [Abstract][Full Text] [Related]
18. Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden.
Guillen-Ahlers H; Suckow MA; Castellino FJ; Ploplis VA
PLoS One; 2010 Feb; 5(2):e9070. PubMed ID: 20140201
[TBL] [Abstract][Full Text] [Related]
19. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
20. Suppression of intestinal tumorigenesis in
Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
